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Dr Vivek Rao (Toronto, Canada). You mentioned at the outset
that this is a physiologic controller system, but it seems to me you
are still setting your speed and algorithms for inducing pulse. Does
your controller allow you to modify it on the basis of the native
heart rate? If your patient is exercising and the native heart rate in-
creases, will this controller automatically change your ventricular
assist device setting?
Dr Asgari. Yes, the system is synchronized with ECG that is
measured from ECG sensors, so the LVAD will respond to
increases in heart rate associated with day-to-day physiologic
stresses, such as exercise, climbing stairs, or Valsalva maneuver.
The decreases in heart rate associated with diurnal variation
(eg, sleeping or resting) will be detected, and the LVAD will
respond accordingly. One can define different percentages of
systole and diastole and automatically vary their duration on
the basis of the heart rate. The controller can run the LVAD in a
co-pulsation, counterpulsation, or fixed mode of operation.
This way, it is truly a pump that responds to physiologic demands.ery c January 2014
